The (eXtreme Lateral Interbody Fusion) procedure is a minimally disruptive surgical technique in which the surgeon approaches the spine from the side of the patient’s body, rather than the front or back as in traditional spine surgeries. This side (lateral) approach can reduce the risk of injury to muscles, nerves, and blood vessels.
The (eXtreme Lateral Interbody Fusion) procedure is a minimally disruptive surgical technique in which the surgeon approaches the spine from the side of the patient’s body, rather than the front or back as in traditional spine surgeries. This side (lateral) approach can reduce the risk of injury to muscles, nerves, and blood vessels.
The XLIF technique can provide relief to patients who cannot tolerate traditional open back surgery due to increased risks of longer anaesthesia time, greater blood loss, longer hospitalisation, and slower recovery.
XLIF surgery is a less disruptive alternative for patients who have lived with back or leg pain through years of various failed treatments, including steroid injections, physical therapy, and pain medication.
XLIF may be recommended to treat the following lumbar or lower spine disorders:
During XLIF, surgeons work in areas that are close to nerves on the spinal column. To prevent nerve damage, nerve monitoring, called electromyography or EMG, is used that provides surgeons with real-time information about nerve position relative to his or her instruments.
XLIF is performed under general anaesthesia so you’ll be asleep during surgery. Steps of the surgery include:
Depending on a patient’s condition, additional support, such as screws, plates or rods, may be inserted to stabilize the spine for fusion.
Imaging studies are used in the diagnosis of meningiomas. Computed tomography (CT) and magnetic resonance imaging (MRI) scans are used to provide increased levels of detail.
Classification of Meningiomas
Grade 1: Slow growing and benign. Unlike some cancer cells that infiltrate the brain, a grade 1 meningioma remains separate, but can still expand, exerting pressure on the brain. Around 90% of meningiomas are classified as Grade I.
Grade 2: Faster growing and tend to grow into the brain tissue, making them more difficult to treat. Grade 2 meningiomas have a greater chance of recurrence after treatment. Despite being more aggressive, they are not considered to be cancerous/malignant. Around 7-8% of all meningiomas are Grade 2.
Grade 3: Most aggressive form with a higher recurrence rate.Grade 3 meningiomas can grow into the brain, as well as metastasise (spread) to other organs. These tumours will likely require more aggressive therapy. 2-3% of meningiomas are classified as Grade 3, or malignant.
Because XLIF is less disruptive than conventional surgery, most patients can walk the evening after surgery and are discharged from the hospital within a few days.
Your surgeon and health care team will determine the best course for you, depending on your comfort and other health problems you might have. Your surgeon will discuss with you any appropriate pain medications as well as a prescribed program of activities. In general, XLIF surgery results in quick recovery and return to normal activities.
Possible risks and complications include: